Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,897.50
+48.10
(+0.61%)
ASX 200
7,629.00
+42.00
(+0.55%)
AUD/USD
0.6612
+0.0040
(+0.61%)
OIL
77.99
-0.96
(-1.22%)
GOLD
2,310.10
+0.50
(+0.02%)
Bitcoin AUD
96,040.07
+619.84
(+0.65%)
Shield Therapeutics plc (STX.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1.5500
-0.1000
(-6.06%)
At close: 05:07PM BST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
Currency in USD.
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,187
4,467
1,519
10,387
Cost of revenue
3,416
2,470
980
1,354
Gross profit
2,771
1,997
539
9,033
Operating expenses
Research development
193
1,072
794
2,579
Selling general and administrative
28,268
24,970
17,943
5,903
Total operating expenses
24,976
27,704
20,833
11,187
Operating income or loss
-22,205
-25,707
-20,294
-2,154
Interest expense
905
327
0
0
Income before tax
-37,213
-40,082
-19,907
-1,886
Income tax expense
718
362
-229
744
Income from continuing operations
-37,931
-40,444
-19,678
-2,630
Net income
-37,931
-40,444
-19,678
-2,630
Net income available to common shareholders
-37,931
-40,444
-19,678
-2,630
Basic EPS
-0.12
-0.17
-0.10
-0.02
Diluted EPS
-0.12
-0.17
-0.10
-0.02
Basic average shares
476,634
237,906
204,409
120,682
Diluted average shares
476,634
237,906
204,409
120,682
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.